Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumonia treated with rifampicin attenuates inflammation
2012-003067-22Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rifampicin in community-acquired pneumonia (CAP) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: LTA release and morbidity. Started Nov 2012; status: active.
02
Drugs
rifampicin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2012-003067-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003067-22.